| abstract |
The use of a compound of the formula (I) for the manufacture of a medicamentnfor inhibiting a condition selected from pathological conditions related to organ systemsnwhich respond to estrogen agonists, uterine fibrosis, myeloperoxidase activity,nautoimmune diseases, reperfusion damage in ischemic myocardium, and thensymptoms of premenstrual syndrome:-n nwherein n R 1 and R 2 may be the same or different provided that, when R 1 and R 2 are thensame, each is a methyl or ethyl group,and, when R 1 and R 2 are different, one of themnis a methyl or ethyl group and the other is hydrogen or a benzylgroup. |